Tecentriq
Brand Name: Tecentriq
Generic Name: Atezolizumab
Active
Registration Number
BR-1436
Dosage Form
Concentrate for Solution for Infusion (IV)
Issuance Date
January 11, 2023
Expiry Date
January 11, 2028
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength1200 mg/20 mL (60 mg/mL)
Packaging20 mL Type I colorless borosilicate glass vial with
fluororesin-laminated rubber stopper and aluminum seal with flip-off cap (Box of 1's).
Classification
C
Classification
Prescription Drug (RX)
A
Application
Monitored Release
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
AtezolizumabActive
Monograph: Atezolizumab